Aquino faces Senate ‘Dengvaxia’ probe | Inquirer News

Aquino faces Senate ‘Dengvaxia’ probe

OCHOA, ABAD ALSO PRESENT
/ 10:26 AM December 14, 2017

Former President Benigno S. Aquino III appeared before the Senate investigation on the government’s anti-dengue immunization program, which commenced during his term.

Aquino was present at the Senate hearing on Thursday along with former Executive Secretary Paquito N. Ochoa Jr., and former Budget Secretary Florencio “Butch” Abad.

Article continues after this advertisement

During Monday’s joint hearing of the Senate blue ribbon, health, and finance committees on the issue, Senator Richard Gordon hinted that Aquino had a hand in the failure of the program, which uses Dengvaxia, an anti-dengue vaccine manufactured by French pharmaceutical company Sanofi Pasteur.

FEATURED STORIES

Gordon is the chairman of the Senate blue ribbon committee.

Earlier, Gordon said he invited Aquino to shed light on his alleged 2015 meetings with officials of Sanofi Pasteur.

Article continues after this advertisement

According to Gordon, he sees “strong signs of a conspiracy to buy” the vaccine, starting from the negotiations up to its purchase through the immediate release of P3.5 billion fund for the vaccination program.

Article continues after this advertisement

Also during the last hearing, former Health Secretary Janette Garin denied any corruption, negligence, and midnight deal involved in the program.

Article continues after this advertisement

Sanofi also denied any negligence on the part of their company.

Former President Benigno S. Aquino III and former Executive Secretary Paquito N. Ochoa Jr. at the Senate hearing on the P3.5 billion anti-dengue immunization program of the Department of Health that commenced during his term. (INQUIRER.net / CATHY MIRANDA)

READ: Gordon blames Aquino administration for giving vaccination ‘a bad name’

Article continues after this advertisement

Last week, the Department of Health (DOH) stopped the administration of Dengvaxia vaccine and ordered the close observation of those who had received it. This developed after Sanofi earlier issued an advisory, which said that its vaccine “could lead to more severe symptoms for people who had not previously been infected” by dengue virus.

READ: Citing risks, DOH stops P3.5-B dengue vaccine drive

Present Health Secretary Francisco Duque III said the vaccine was administered to more than 830,000 children in schools, communities, and private hospitals.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Around 12,000 uniformed personnel, including their families and children, were also vaccinated, Duque said.   /kga

TAGS: anti-dengue, dengue, Dengvaxia, Health, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.